We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Welltower
WELL
$169B
| $232K | ﹤0.01% |
+3,535
| New | +$253K |
|
|
ACAS
902
DELISTED
American Capital Ltd
ACAS
| $232K | ﹤0.01% |
+17,102
| New | +$249K |
|
903
D.R. Horton
DHI
$40B
| $231K | ﹤0.01% |
8,446
+446
| +6% | +$12K |
|
|
GHL
904
DELISTED
Greenhill & Co., Inc.
GHL
| $231K | ﹤0.01% |
+5,600
| New | +$227K |
|
905
Applied Industrial Technologies
AIT
$12.8B
| $230K | ﹤0.01% |
+5,792
| New | +$246K |
|
906
Bankunited
BKU
$3.37B
| $230K | ﹤0.01% |
6,400
-600
| -9% | -$20.5K |
|
907
PUT
Citigroup
C
$222B
| $230K | ﹤0.01% |
1,250
| – | – |
|
908
HEICO Corp Class A
HEI.A
$36B
| $230K | ﹤0.01% |
+8,859
| New | +$222K |
|
909
IPG Photonics
IPGP
$3.61B
| $230K | ﹤0.01% |
2,700
-3,114
| -54% | -$293K |
|
910
Zebra Technologies
ZBRA
$14B
| $230K | ﹤0.01% |
+2,072
| New | +$215K |
|
|
SWN
911
DELISTED
Southwestern Energy Company
SWN
| $230K | ﹤0.01% |
+10,140
| New | +$260K |
|
|
SCAI
912
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $230K | ﹤0.01% |
+6,000
| New | +$227K |
|
913
BioCryst Pharmaceuticals
BCRX
$2.28B
| $228K | ﹤0.01% |
+15,300
| New | +$174K |
|
914
Xylem
XYL
$27.3B
| $228K | ﹤0.01% |
+6,141
| New | +$223K |
|
915
Edison International
EIX
$28.2B
| $227K | ﹤0.01% |
4,083
-39,618
| -91% | -$2.38M |
|
916
Tronox
TROX
$932M
| $227K | ﹤0.01% |
+15,500
| New | +$292K |
|
|
SFS
917
DELISTED
Smart & Final Stores, Inc.
SFS
| $227K | ﹤0.01% |
+12,684
| New | +$225K |
|
|
AVG
918
DELISTED
AVG Technologies N.V.
AVG
| $227K | ﹤0.01% |
+8,341
| New | +$203K |
|
919
Dine Brands
DIN
$456M
| $226K | ﹤0.01% |
+2,276
| New | +$227K |
|
|
K
920
DELISTED
Kellanova
K
| $226K | ﹤0.01% |
+3,834
| New | +$229K |
|
|
ICON
921
DELISTED
Iconix Brand Group, Inc.
ICON
| $226K | ﹤0.01% |
+903
| New | +$252K |
|
922
Empire State Realty Trust
ESRT
$872M
| $225K | ﹤0.01% |
+13,200
| New | +$238K |
|
923
CALL
SPDR Gold Trust
GLD
$131B
| $225K | ﹤0.01% |
+1,500
| New | +$172K |
|
|
924
SPDR Gold Trust
GLD
$131B
| $225K | ﹤0.01% |
+2,000
| New | +$229K |
|
|
GGP
925
DELISTED
GGP Inc.
GGP
| $224K | ﹤0.01% |
+8,744
| New | +$244K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.